Press Release: A new report by Informa Markets, organizers of Arab Health and Medlab Middle East, the MENA region’s leading exhibitions for the healthcare and laboratory industries, has revealed investment in new healthcare technology has become the top priority for 2021.
Titled Voice of the Healthcare Industry Market Outlook 2021 and produced by Omnia Health Insights, the report highlights that 45% of respondents identified technology as the best opportunity for business growth in the GCC, with digitization creating the most significant impact according to the agents, dealers and distributors, clinics, medical practices, consultancies and manufacturers surveyed.
Solenne Singer, Group Director for Informa Markets, said: “As a result of the coronavirus pandemic and the global health crisis, there has been a distinct shift in priorities with the focus now on implementing new technologies for better healthcare delivery.
“Digitalisation, blockchain and Big Data are growing in prominence, and according to our report, AI is the second most impactful area of tech overall, followed by robotics. 23% of those surveyed from the GCC placed a much higher priority for investment in this area of new technology.”
Technology will take center stage at the 2022 edition of Arab Health and Medlab Middle East. A series of panel discussions and keynote presentations from leaders within the industry will highlight the latest advancements within the sector. Meanwhile, innovation will be prominent with the return of the Arab Health Innov8 Talks, while Medlab Middle East will showcase the latest innovations from the laboratory industry via a range of product displays and talks.
According to the report, funding was outlined as the most significant challenge public and private medical practices faced. This was also true of charities and non-profit organizations, creating the greatest barrier to implementing new technology.
When asked about emerging trends in the next 12 months, the number one response was value-based healthcare. This is when healthcare providers are rewarded for helping patients improve their health, reduce the effects and incidence of chronic disease, and live healthier lives in an evidence-based way. Almost half of all respondents placed this as the top forecasted trend.
- Selecta Partners With Genovis for $ 604 Million to Innovate in Gene TherapyThe American biotechnology company, Selecta, announced a strategic licensing agreement to develop the next generation of “IgG” proteins with the Swedish company Genovis for enzyme technology and IdeXork (Xork). This partnership leverages Genovis’ proprietary immunoglobulin G (IgG) protease and Selecta’s […]
- Novartis is Considering Selling Sandoz or spinning off its Business Next YearNovartis is reviewing a range of options related to its generic subsidiary Sandoz, including separating or spinning off from the business. This comes due to mounting price pressures in the off-patent pharmaceutical sector, as the Swiss pharmaceutical giant is focused […]
- Novartis Collaborates with Abu Dhabi Department of Health to Enhance the Digital Healthcare SystemThe Swiss pharmaceutical company Novartis signed a memorandum of understanding with the Department of Health – Abu Dhabi, the healthcare regulator in the Emirate of Abu Dhabi, as part of the department’s participation in GITEX Technology Week 2021, which aims […]
- Bristol-Myers Squibb Plans to Acquire Aurinia Pharmaceuticals for $ 3.6 BillionBristol-Myers Squibb plans to buy smaller biopharmaceuticals competitor Aurinia for $3.6 billion. Sources said the New York-based company had recently contacted Aurinia about the deal, noting that no final decision had been made and Bristol-Myers could choose any potential deal. […]
- Sodexo Meets the Demands of the Changing Healthcare Market in the Middle EastUnited Arab Emirates: Sodexo Middle East, a leading provider of services aimed at improving the quality of life, is committed to meeting the diverse market needs of the region’s healthcare sector by offering a diverse range of innovative services to […]
The previous edition of Arab Health and Medlab Middle East, which took place earlier this year, welcomed 22,800 visitors from 172 countries who connected with 1,700 exhibitors generating AED767.7 million new business deals. A total of 61 countries were represented by exhibitors, which included 30 international pavilions.
“The COVID-19 pandemic has affected every single member of the healthcare community, both personally and professionally. We are, however, at a point where the industry is ready to move forward, return to live events and secure new business deals. The last edition of Arab Health and Medlab underscored this desire, and we now look forward to welcoming participants once again in 2022,” added Singer.
The 2022 edition of the show, which returns as a co-located event for the healthcare and laboratory industries, will take place from 24 – 27 January at the Dubai World Trade Centre. This year’s theme is ‘United by business, forging ahead’. The event is once again expected to be supported by a host of government entities, industry leaders and influencers in their respective sectors.
As part of Informa’s commitment to providing the highest hygiene and safety levels, the event will again take place under the protocols introduced via the company’s Informa AllSecure health and safety mandate. The enhanced measures include 35 guidelines covering all aspects of cleaning and hygiene, social distancing measures, and the use of PPE, screening, and a track and trace in conjunction with local authorities.
About Arab Health
As part of Informa Markets commitment to provide the highest hygiene levels at all events, the company has launched Informa AllSecure – a 35-point guide to ensuring attendee and staff safety.
Arab Health is the largest healthcare event in the Middle East and is organised by Informa Markets. Established 47 years ago, Arab Health provides a platform for the world’s leading manufacturers, wholesalers and distributors to meet the medical and scientific community in the Middle East and subcontinent.
Arab Health Congress is reputed for delivering the highest quality Continuing Medical Education (CME) Conferences to medical professionals in the region.
Arab Health 2022 will take place from 24-27 January 2022 at the Dubai World Trade Centre, Dubai, United Arab Emirates.
About Medlab Middle East
As the MENA region’s largest medical laboratory exhibition and congress, Medlab Middle East, plays a crucial role in developing the value of laboratory medicine in transforming tomorrow’s diagnostics by providing a platform for laboratory industry leaders, including manufacturers, dealers and distributors, to share best practice, showcase innovations, collaborate and network.
Medlab Middle East stems from 15 years of growth alongside the MENA region’s largest healthcare event, Arab Health. Moving into its 21st year, this annual medical laboratory meeting brings together exhibitors and attendees from over 140+ countries.
Medlab Middle East will take place from 24-27 January 2022 at the Dubai World Trade Centre, Dubai, UAE.